Article

Multi-omics analysis reveals aspirin is associated with reduced risk of Alzheimer’s disease

2025-04-08

Abstract excerpt

The urgent need for safe and effective therapies for Alzheimer’s disease (AD) has spurred a growing interest in repurposing existing drugs to treat or prevent AD. In this study, we combined multi-omics and clinical data to investigate possible repurposing opportunities for AD. We performed transcriptome-wide association studies (TWAS) to construct gene expression signatures of AD from publicly available GWAS summa...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: f8c8df58-4b4d-55da-8302-bf363d2cbfac
DOI: 10.1101/2025.04.07.25325038

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Multi-omics analysis reveals aspirin is associated with reduced risk of Alzheimer’s diseaseDOI 10.1101/2025.04.07.25325038Read

Integrating genetically predicted transcriptomic signatures with longitudinal real-world data enables scalable drug repurposing for Alzheimer’s diseaseSemantic proximity Read

Leveraging existing data sets to generate new insights into Alzheimer's disease biology in specific patient subsets.Semantic proximity Read

AlzGPS: A Genome-wide Positioning Systems Platform to Catalyze Multi-omics for Alzheimer’s Therapeutic DiscoverySemantic proximity Read

Network-based Translation of GWAS Findings to Pathobiology and Drug Repurposing for Alzheimer’s DiseaseSemantic proximity Read

AlzGPS: a genome-wide positioning systems platform to catalyze multi-omics for Alzheimer’s drug discoverySemantic proximity Read

Aspirin Use and Risk of Alzheimer's Disease: A 2-Sample Mendelian Randomization Study.Semantic proximity Read

Network pharmacology-based discovery and experimental validation of novel drug repurposing candidates in Alzheimer’s DiseaseSemantic proximity Read

Transformative Network Modeling of Multi-omics Data Reveals Detailed Circuits, Key Regulators, and Potential Therapeutics for Alzheimer’s DiseaseSemantic proximity Read

Combining genetics with real-world patient data enables ancestry-specific target identification and drug discovery in Alzheimer’s diseaseSemantic proximity Read

Single‐microglia transcriptomic transition network‐based prediction and real‐world patient data validation identifies ketorolac as a repurposable drug for Alzheimer's diseaseSemantic proximity Read

Screening novel drug candidates for Alzheimer’s disease by an integrated network and transcriptome analysisSemantic proximity Read

Systematic characterization of multi-omics landscape between gut microbial metabolites and GPCRome in Alzheimer’s diseaseSemantic proximity Read